Insider Trading Summary for Eyepoint Pharmaceuticals, Inc. (EYPT): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Apr-24 5:27 PM View:	30-Mar-24 Payment of Exercise ($528.04K)	Paggiarino Dario A. Chief Medical Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	161% 25.71K to 67.08K	0	0	--	--	Show Txns Hide Txns

21-Aug-24 4:01 PM View:	21-Aug-24 Private Purchase $39.75K	Ando Goran Director		Eyepoint Pharmaceuticals, Inc. - EYPT	61% 8.15K to 13.15K	0	0	--	--	Show Txns Hide Txns

16-Jul-24 4:24 PM View:	12-Jul-24 Sale ($18.62K)	Guyer David R Director		Eyepoint Pharmaceuticals, Inc. - EYPT	(75%) 7.4K to 1.85K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:38 PM View:	09-Feb-24 Payment of Exercise ($105.29K)	Jones David Scott SVP & Chief Commercial Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	67% 26.82K to 44.92K	0	0	--	--	Show Txns Hide Txns

21-Aug-24 4:32 PM View:	20-Aug-24 Private Purchase $20.00K	Dicicco Wendy F Director		Eyepoint Pharmaceuticals, Inc. - EYPT	35% 7.4K to 9.97K	0	0	--	--	Show Txns Hide Txns

28-May-24 10:00 PM View:	25-May-24 Payment of Exercise ($40.48K)	Elston George Chief Financial Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	90% 24.93K to 47.48K	0	0	--	--	Show Txns Hide Txns

16-Jan-24 6:01 PM View:	11-Jan-24 Private Sale Duplicate ($37.16M)	Liu Ye Director		Eyepoint Pharmaceuticals, Inc. - EYPT	(97%) 3.01M to 100.22K	0	0	--	--	Show Txns Hide Txns

09-Jan-24 9:11 PM View:	06-Jan-24 Payment of Exercise ($121.71K)	Pine Michael Craig Chief Corp Dev.&Strat. Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	156% 5.34K to 13.66K	0	0	--	--	Show Txns Hide Txns

25-Jun-24 4:16 PM View:	23-Jun-24 Option Exercise 0	Adamis Anthony P Director		Eyepoint Pharmaceuticals, Inc. - EYPT	100% 2.0K to 4.0K	0	0	--	--	Show Txns Hide Txns

21-Aug-24 4:01 PM View:	19-Aug-24 Private Purchase $99.75K	Zaderej Karen L. Director		Eyepoint Pharmaceuticals, Inc. - EYPT	725% 2.0K to 16.5K	0	0	--	--	Show Txns Hide Txns

12-Jul-24 5:04 PM View:	10-Jul-24 Payment of Exercise ($70.03K)	Duker Jay S. President and CEO Director		Eyepoint Pharmaceuticals, Inc. - EYPT	107% 29.22K to 60.53K	0	0	--	--	Show Txns Hide Txns

08-May-24 4:23 PM View:	06-May-24 Market Purchase $10.08M	Cormorant Asset Management,... 10% Owner		Eyepoint Pharmaceuticals, Inc. - EYPT	136% 3.53M to 8.32M	$10.08M 24%	0	$11.86	--	Show Txns Hide Txns

16-Jan-24 6:55 PM View:	11-Jan-24 Private Sale ($37.16M)	Ocumension Therapeutics Director		Eyepoint Pharmaceuticals, Inc. - EYPT	(97%) 3.01M to 100.22K	0	0	--	--	Show Txns Hide Txns

20-Aug-24 4:04 PM View:	16-Aug-24 Private Purchase $25.00K	Lurker Nancy Director		Eyepoint Pharmaceuticals, Inc. - EYPT	18% 190.56K to 224.52K	0	0	--	--	Show Txns Hide Txns

Eyepoint Pharmaceuticals, Inc. (EYPT)

Last Year

22-Nov-23 -- 21-Nov-24

Company Sentiment

Scientific & Technical Instruments

Electronics

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	$10.08M	$11.86
Sell:	0	--